SCHEMBL6981826

SCHEMBL6981826

N#Cc1ccc(CCC(=O)N2CCCc3cc(C(=O)N4CCCCC4)ccc32)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 3/20 0.52
PDK2 Q15119 3/20 0.52
PDK3 Q15120 3/20 0.52
PDK4 Q16654 3/20 0.52
TP53 P04637 1/20 0.46
CDK1 P06493 1/20 0.44
HPGD P15428 2/20 0.44
HDAC1 Q13547 2/20 0.44
HDAC8 Q9BY41 2/20 0.44
HDAC6 Q9UBN7 2/20 0.44
KDM1A O60341 2/20 0.44
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
AVPR2 P30518 2/20 0.41
OXTR P30559 2/20 0.41
AVPR1A P37288 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6987041 0.91 CDK1 (0.45) PDK1PDK2PDK3PDK4TP53
SCHEMBL7410530 0.90 TP53 (0.45) PDK1PDK2PDK3PDK4TP53
SCHEMBL6985351 0.87 ALDH1A1 (0.54) PDK1PDK2PDK3PDK4TP53
Hydrochloric Acid SCHEMBL6979759 0.85 PDK1 (0.51) PDK1PDK2PDK3PDK4HPGD
SCHEMBL6985246 0.84 TP53 (0.51) PDK1PDK2PDK3PDK4TP53
SCHEMBL6977395 0.84 TP53 (0.46) TP53HPGDHDAC1HDAC8HDAC6
SCHEMBL6986538 0.82 TP53 (0.49) PDK1PDK2PDK3PDK4TP53
SCHEMBL6979722 0.82 TP53 (0.48) PDK1PDK2PDK3PDK4TP53
SCHEMBL7959087 0.82 TP53 (0.48) PDK1PDK2PDK3PDK4TP53
SCHEMBL6977738 0.82 TP53 (0.51) TP53HPGDHDAC1HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed